Acid-degradable PEG Lipid (ADP-2k)
DC60638
View product →
ALC-0159 is a PEG/lipid conjugate (i.e. PEGylated lipid). Formulations containing ALC-0159 have been used in the development of lipid nanoparticles (LNPs) for the delivery of mRNA-based vaccines.
| CAS No. | 1849616-42-7 |
| Chemical Name | ALC-0159 (di-C18) |
| Synonyms | ALC-0159;ALC 0159;ALC0159 |
| SMILES | O=C(N(CCCCCCCCCCCCCCC)CCCCCCCCCCCCCC)COCCOC |
| Formula | (C2H4O)NC31H63NO2 |
| M.Wt | 2400.24 |
| Purity | >99% |
| Storage | -20°C, protect from light |
| Shipping condition | Ships from Shanghai; packaging confirmed at order. |
| Publication | Public Assessment Report Authorisation for Temporary Supply COVID-19 mRNA Vaccine BNT162b2 (BNT162b2 RNA) concentrate for solution for injection"""" (PDF). Regulation 174. MHRA. 15 December 2020. |
| Product classification | PEGylated lipids |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 4.1663 mL | 0.8333 mL | 0.4166 mL |
| 25 mg | 10.4156 mL | 2.0831 mL | 1.0416 mL |
| 50 mg | 20.8313 mL | 4.1663 mL | 2.0831 mL |
| 100 mg | 41.6625 mL | 8.3325 mL | 4.1663 mL |
| 250 mg | 104.1563 mL | 20.8313 mL | 10.4156 mL |
Contact our team with the catalog number and requested quantity.